The short version of circadian rhythm fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-04. Anything still debated is marked as such rather than presented as settled.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
In doing so, Zita assured herself that in death, she and her husband would remain by each other's side. When the procession of mourners arrived at the gates of the Imperial Crypt, the herald who knocked on the door during the traditional "admission ceremony" introduced her as Zita, Her Majesty the Empress and Queen.
== Related compounds == N-Methyliminodiacetic acid (MIDA), the N-methyl derivative of IDA Imidodiacetic acid, the amino diacetic acid N-(2-Carboxyethyl)iminodiacetic acid, a more biodegradable analogue of NTA N-hydroxyiminodiacetic acid (HIDA), HON(CH2CO2H)2 (registry number = 87339-38-6) See HIDA scan.
Second, Downstream-peptides are consistently positioned in a place that is consistent with a cis-regulatory role in regulating the downstream ORFs, although the biological role of the ORFs is unknown. Third, the pseudoknot structure has a moderate complexity that is typical of riboswitches. Finally, the observation of regulation of a downstream ORF by nitrogen availability also suggests a cis-regulatory role of the element. This hypothesis is supported by biochemical and genetic data. First, both Downstream-peptide RNAs and glnA RNAs selectively bind glutamine. Second, reporter gene analysis of the Downstream-peptide motif revealed that this RNA promotes reporter gene expression upon binding of glutamine and can therefore be considered an activating riboswitch. Possible candidates to be regulated by the Downstream-peptide motif are genes that frequently carry the Downstream-peptide motif in their 5′UTR and encode small, unknown proteins that contain DUF4278 and are putative regulators of glutamine synthetase. This hypothesis is supported by the finding that expression of the DUF4278-containing glutamine synthetase inhibitory factor IF17 encoding gene gifB was shown to be regulated by the structurally related glnA RNA motif. Downstream-peptide RNAs overlap a predicted non-coding RNA called yfr6 that is over 200 nucleotides in length, but it was proposed that only the upstream region (corresponding to the Downstream-peptide motif) functions as an RNA structure. A distinct predicted non-coding RNA called yfr14 overlaps both yfr6 and Downstream-peptide RNAs.
Portugal's territory comprises mainland Portugal and the Azores and Madeira archipelagos. The mainland, commonly referred to as Continental Portugal, is located in the southwest of the Iberian Peninsula in Southwestern Europe, while Madeira and the Azores lie in the Atlantic Ocean. Portugal's land area is 92,225 km2 (35,608 sq mi), although Portuguese law defines the country's size as 156,597 km2 (60,462 sq mi) which includes about 64,000 km2 (24,711 sq mi) of ocean waters. Portugal's exclusive economic zone extends 1,727,408 km2 (666,956 mi2), making it one of the largest in the European Union. The country is over two-thirds wilderness, almost one-fourth agricultural, and the remainder human settlements. Portugal's highest point is the summit of Mount Pico, located on Pico Island in the Azores, which rises to an elevation of 2,351 m (7,713 ft) above sea level. Portugal can be divided into four morphostructural units: the Hesperian Massif, which occupies most of mainland Portugal; the sedimentary borderlands of the massif, forming the Lusitanian and Algarve basins; the Lower Tagus and Alvalade sedimentary basins; and the volcanic submarine ranges that form the Azores and Madeira. Its geological and geomorphological features are largely the product of the Variscan, responsible for the formation of the Hesperian Massif, and later the Tethys–Atlantic cycle, responsible for the remaining units.
Election forensics is the use of statistics to determine if election results are normal or abnormal. It is also used to look into and detect the cases concerning gerrymandering. Forensic accounting is the study and interpretation of accounting evidence, financial statement namely: Balance sheet, Income statement, Cash flow statement. Forensic aerial photography is the study and interpretation of aerial photographic evidence. Forensic anthropology is the application of physical anthropology in a legal setting, usually for the recovery and identification of skeletonized human remains. Forensic archaeology is the application of a combination of archaeological techniques and forensic science, typically in law enforcement. Forensic astronomy uses methods from astronomy to determine past celestial constellations for forensic purposes. Forensic botany is the study of plant life in order to gain information regarding possible crimes. Forensic chemistry is the study of detection and identification of illicit drugs, accelerants used in arson cases, explosive and gunshot residue. Forensic dactyloscopy is the study of fingerprints. Forensic document examination or questioned document examination answers questions about a disputed document using a variety of scientific processes and methods. Many examinations involve a comparison of the questioned document, or components of the document, with a set of known standards. The most common type of examination involves handwriting, whereby the examiner tries to address concerns about potential authorship.
Sources: en.wikipedia.org
Laidlaw later said he was thankful Antonov was on the Half-Life 2 team, because his experience in recreating Eastern Europe helped them stand out from sci-fi's "wearisome influences of Star Wars and Blade Runner and Alien". In 2017, Blake Hester wrote for Vice magazine that City 17 as a setting "is often regarded as being fantastic". It has been listed as one of the best or most iconic cities in gaming by PC Gamer, TheGamer, and DualShockers. Konstantinos Dimopoulos, a game designer who produced an unofficial map of the city in 2018, claimed that it is "one of the most successful, coherent, economically designed, and memorable urban environments ever crafted". As an example, he notes that the Citadel's imposing height and reoccurring appearances in the game make it "act as a major landmark that keeps players both oriented [in the game world] and focused on their goal". City 17 was made the setting of Half-Life 2's 2020 sequel Half-Life Alyx.
=== Antibody detection === A benefit of antibody detection (ELISA) is that protein identification on a microorganism becomes faster than a western blot. Antibody detection works by attaching an indicator to an antibody with a known specificity and observing whether the antibody attaches. ELISA can also indicate viral presence and is highly specific, having a detection specificity of 10−9-10−12 moles per litre detection. By knowing the epitope sequence of the antibody, ELISA can also be used for antigen detection in a sample.
The proportions [given by Webb] indicate that this might have been a squid-like form, and not an Octopus. The "breadth" is evidently that of the softened and collapsed body, and would represent an actual maximum diameter in life of at least 7 feet and a probable weight of 4 or 5 tons for the body and head. These dimensions are decidedly larger than those of any of the well-authenticated Newfoundland specimens. It is perhaps a species of Architeuthis. Verrill soon changed his mind about the identity of the creature. In the January 3 issue of the New York Herald, he wrote that the carcass was indeed that of a giant octopus. However, the paper did not state that Verrill was the author of the article. The article read:
Several captured Boers, including Lotter and Scheepers, who was captured when he fell ill with appendicitis, were executed by the British for treason or for capital crimes such as the murder of British prisoners or unarmed civilians. Some of the executions took place in public, to deter further disaffection. Fresh Boer forces under Jan Christiaan Smuts, joined by the surviving rebels under Kritzinger, made another attack on the Cape in September 1901. They suffered severe hardships and were hard pressed by British columns, but eventually rescued themselves by routing some of their pursuers at the Battle of Elands River and capturing their equipment. From then until the end of the war, Smuts increased his forces from among Cape rebels until they numbered 3,000. However, no general uprising took place, and the situation in the Cape remained stalemated. In January 1902, Boer leader Manie Maritz was implicated in the Leliefontein massacre in the far Northern Cape.
Sources: en.wikipedia.org
American Association of Physical Anthropologists Biological Anthropology Section of the American Anthropological Association British Association of Biological Anthropologists and Osteoarchaeologists Canadian Association for Physical Anthropology Journals
=== Bjerknes feedback === The close relationship between ocean temperatures and the strength of the trade winds was first identified by Jacob Bjerknes in 1969. Bjerknes also hypothesized that ENSO was a positive feedback system where the associated changes in one component of the climate system (the ocean or atmosphere) tend to reinforce changes in the other. This process is known as Bjerknes feedback. For example, during the growth of El Niño, the reduced contrast in ocean temperatures across the Pacific results in weaker trade winds, further reinforcing the El Niño state. Although these associated changes in the ocean and atmosphere often occur together, the state of the atmosphere may resemble a different ENSO phase than the state of the ocean or vice versa. Because their states are closely linked, the variations of ENSO may arise from changes in both the ocean and atmosphere and not necessarily from an initial change of exclusively one or the other. Conceptual models explaining how ENSO operates generally accept the Bjerknes feedback hypothesis. However, ENSO would perpetually remain in one phase if Bjerknes feedback were the only process occurring. Several theories have been proposed to explain how ENSO can change from one state to the next despite the positive feedback. These explanations broadly fall under two categories. In one view, the Bjerknes feedback naturally triggers negative feedbacks that end and reverse the abnormal state of the tropical Pacific.
In an experiment described in the 2016 paper, rhesus macaques were infected with Ebola virus and treated with a combination of ansuvimab and another antibody isolated from the same subject, mAb100. Three doses of the combination were given once a day starting 1 day after the animals were infected. The control animal died and the treated animals all survived. In a second experiment described in the 2016 paper, rhesus macaques were infected with Ebola virus and only treated with ansuvimab. Three doses of ansuvimab were given once a day starting 1 day or 5 days after the animals were infected. The control animals died and the treated animals all survived. Unpublished data referred to in a publication of the 2018 Phase I clinical trial results of ansuvimab, reported that a single infusion of ansuvimab provided full protection of rhesus macaques and was the basis of the dosing used for human studies.
The calculation uses 8,033 years, the mean-life derived from Libby's half-life of 5,568 years, not 8,267 years, the mean-life derived from the more accurate modern value of 5,730 years. Libby's value for the half-life is used to maintain consistency with early radiocarbon testing results; calibration curves include a correction for this, so the accuracy of final reported calendar ages is not affected.
== Signaling == Activation of the adenosine A1 receptor by an agonist causes binding of Gi1/2/3 or Go protein. Binding of Gi1/2/3 causes an inhibition of adenylate cyclase and, therefore, a decrease in the cAMP concentration. An increase of the inositol triphosphate/diacylglycerol concentration is caused by an activation of phospholipase C, whereas the elevated levels of arachidonic acid are mediated by DAG lipase, which cleaves DAG to form arachidonic acid. Several types of potassium channels are activated but N-, P-, and Q-type calcium channels are inhibited.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.